These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39160538)

  • 21. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
    Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
    J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic landscape of TP53-mutated myeloid malignancies.
    Abel HJ; Oetjen KA; Miller CA; Ramakrishnan SM; Day RB; Helton NM; Fronick CC; Fulton RS; Heath SE; Tarnawsky SP; Nonavinkere Srivatsan S; Duncavage EJ; Schroeder MC; Payton JE; Spencer DH; Walter MJ; Westervelt P; DiPersio JF; Ley TJ; Link DC
    Blood Adv; 2023 Aug; 7(16):4586-4598. PubMed ID: 37339484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review.
    Zeichner SB; Alghamdi S; Elhammady G; Poppiti RJ
    Asian Pac J Cancer Prev; 2014; 15(4):1603-9. PubMed ID: 24641375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.
    Wang X; Dai H; Wang Q; Wang Q; Xu Y; Wang Y; Sun A; Ruan J; Chen S; Wu D
    PLoS One; 2013; 8(4):e61341. PubMed ID: 23613835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
    Stomper J; Meier R; Ma T; Pfeifer D; Ihorst G; Blagitko-Dorfs N; Greve G; Zimmer D; Platzbecker U; Hagemeijer A; Schmitt-Graeff I; Lübbert M
    Clin Epigenetics; 2021 Apr; 13(1):77. PubMed ID: 33845873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
    Hosono N
    Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.
    Hou HA; Chou WC; Kuo YY; Liu CY; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Chen YC; Tien HF
    Blood Cancer J; 2015 Jul; 5(7):e331. PubMed ID: 26230955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
    Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
    Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.
    Yoshizato T; Nannya Y; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Suzuki H; Nagata Y; Sato Y; Kakiuchi N; Matsuo K; Onizuka M; Kataoka K; Chiba K; Tanaka H; Ueno H; Nakagawa MM; Przychodzen B; Haferlach C; Kern W; Aoki K; Itonaga H; Kanda Y; Sekeres MA; Maciejewski JP; Haferlach T; Miyazaki Y; Horibe K; Sanada M; Miyano S; Makishima H; Ogawa S
    Blood; 2017 Apr; 129(17):2347-2358. PubMed ID: 28223278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic and genetic characterization of nonacute
    Patel SS; Ho C; Ptashkin RN; Sadigh S; Bagg A; Geyer JT; Xu ML; Prebet T; Mason EF; Seegmiller AC; Morgan EA; Steensma DP; Winer ES; Wong WJ; Hasserjian RP; Weinberg OK
    Blood Adv; 2019 May; 3(9):1540-1545. PubMed ID: 31085507
    [No Abstract]   [Full Text] [Related]  

  • 31. TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.
    Tashakori M; Kadia T; Loghavi S; Daver N; Kanagal-Shamanna R; Pierce S; Sui D; Wei P; Khodakarami F; Tang Z; Routbort M; Bivins CA; Jabbour EJ; Medeiros LJ; Bhalla K; Kantarjian HM; Ravandi F; Khoury JD
    Blood; 2022 Jul; 140(1):58-72. PubMed ID: 35390143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
    El-Menoufy MAM; Mourad ZI; Farahat NM
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China.
    Dou X; Dan C; Zhang D; Zhou H; He R; Zhou G; Zhu Y; Fu N; Niu B; Xu S; Liao Y; Luo Z; Yang L; Zhang H; Xu Y; Zhan Q; Chen W; Yang Z; Tang X; Zhang H; Xiao Q; Chen J; Liu L; Wang Y; Pei L; Wang L
    Int J Cancer; 2024 Dec; 155(12):2253-2264. PubMed ID: 39109820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA
    J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
    Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
    Krauth MT; Eder C; Alpermann T; Bacher U; Nadarajah N; Kern W; Haferlach C; Haferlach T; Schnittger S
    Leukemia; 2014 Jul; 28(7):1449-58. PubMed ID: 24402164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.
    Poiré X; Labopin M; Polge E; Volin L; Finke J; Ganser A; Blaise D; Yakoub-Agha I; Beelen D; Forcade E; Lioure B; Socié G; Niederwieser D; Labussière-Wallet H; Maertens J; Cornelissen J; Craddock C; Mohty M; Esteve J; Nagler A
    Am J Hematol; 2020 Mar; 95(3):282-294. PubMed ID: 31876307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
    Falk IJ; Willander K; Chaireti R; Lund J; Nahi H; Hermanson M; Gréen H; Lotfi K; Söderkvist P
    Eur J Haematol; 2015 Apr; 94(4):355-62. PubMed ID: 25156865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
    Gaidzik VI; Bullinger L; Schlenk RF; Zimmermann AS; Röck J; Paschka P; Corbacioglu A; Krauter J; Schlegelberger B; Ganser A; Späth D; Kündgen A; Schmidt-Wolf IG; Götze K; Nachbaur D; Pfreundschuh M; Horst HA; Döhner H; Döhner K
    J Clin Oncol; 2011 Apr; 29(10):1364-72. PubMed ID: 21343560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.